Accurate calculation of blood volume to be processed by apheresis to achieve target CD34+ cell numbers for PBPC transplantation

被引:16
作者
Trickett, AE
Smith, S
Kwan, YL
机构
[1] Univ New S Wales, Sydney, NSW, Australia
[2] St George Hosp, SEALS, Sydney, NSW, Australia
[3] St George Hosp, BMT Lab, Sydney, NSW, Australia
关键词
CD34; peripheral blood progenitor cells (PBPC); transplantation;
D O I
10.1080/146532401753156359
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Background In recent years there have been clear improvements in the procurement of peripheral blood progenitor cells (PBPC) for autologous transplantation, such as the description of more effective mobilization regimens and the use of CD34 monitoring to determine the appropriate time to start collection. However currently there is no accurate method of predicting the volume of blood required to be processed by apheresis to yield the target number of CD34(+) progenitor cells. Methods This study was performed to determine whether there is a correlation between the harvested number of CD34(+) cells per kilogram body weight and the 'CD34 prediction score' calculated from the concentration of CD34(+) cells in the blood prior to harvest the blood volume processed, and the patient's weight Results A strong correlation between the CD34 prediction score and the quantity of CD34+ cells harvested was found. This facilitated the construction of an algorithm for calculating the minimum volume of blood required to be processed by apheresis to yield the target number of CD34(+) cells. Subsequent validation of the algorithm facilitated successful tailoring of the apheresis time Discussion The ability to accurately calculate the minimum volume of blood to be processed by apheresis to yield a target number of PBPC produces significant benefits in patient management, cost savings and equipment utilization.
引用
收藏
页码:5 / 10
页数:6
相关论文
共 8 条
[1]  
BENDER J, 1994, MULHOUSE MANUAL, P31
[2]  
Chang A, 1996, J Hematother, V5, P605, DOI 10.1089/scd.1.1996.5.605
[3]   Analysis of the effect of prior therapy on progenitor cell yield: use of a chemotherapy scoring system [J].
Drake, M ;
Ranaghan, L ;
Morris, TCM ;
Nolan, L ;
Desai, ZR ;
Irvine, AE ;
Jordan, A ;
Magill, K ;
Price, S .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 98 (03) :745-749
[4]   INCREASE IN CIRCULATING COLONY-FORMING-UNITS GRANULOCYTE-MACROPHAGE DURING LARGE-VOLUME LEUKAPHERESIS - EVALUATION OF A NEW CELL SEPARATOR [J].
HILLYER, CD ;
TIEGERMAN, KO ;
BERKMAN, EM .
TRANSFUSION, 1991, 31 (04) :327-332
[5]  
JANSSEN WE, 1995, HEMATOPOIETIC STEM C, P403
[6]  
Passos-Coelho J L, 1995, J Hematother, V4, P11, DOI 10.1089/scd.1.1995.4.11
[7]  
Rowley SD, 1999, CYTOTHERAPY, V1, P311
[8]  
Schots R, 1996, BONE MARROW TRANSPL, V17, P509